Literature DB >> 30867296

Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae.

Jyoti Verma1, Satyabrata Bag1, Bipasa Saha1, Pawan Kumar1, Tarini Shankar Ghosh1, Mayanka Dayal1, Tarosi Senapati1, Seema Mehra1, Prasanta Dey1, Anbumani Desigamani1, Dhirendra Kumar1, Preety Rana1, Bhoj Kumar2, Tushar K Maiti2, Naresh C Sharma3, Rupak K Bhadra4, Ankur Mutreja1,5, G Balakrish Nair6, Thandavarayan Ramamurthy1, Bhabatosh Das7,8.   

Abstract

The Bay of Bengal is known as the epicenter for seeding several devastating cholera outbreaks across the globe. Vibrio cholerae, the etiological agent of cholera, has extraordinary competency to acquire exogenous DNA by horizontal gene transfer (HGT) and adapt them into its genome for structuring metabolic processes, developing drug resistance, and colonizing the human intestine. Antimicrobial resistance (AMR) in V. cholerae has become a global concern. However, little is known about the identity of the resistance traits, source of AMR genes, acquisition process, and stability of the genetic elements linked with resistance genes in V. cholerae Here we present details of AMR profiles of 443 V. cholerae strains isolated from the stool samples of diarrheal patients from two regions of India. We sequenced the whole genome of multidrug-resistant (MDR) and extensively drug-resistant (XDR) V. cholerae to identify AMR genes and genomic elements that harbor the resistance traits. Our genomic findings were further confirmed by proteome analysis. We also engineered the genome of V. cholerae to monitor the importance of the autonomously replicating plasmid and core genome in the resistance profile. Our findings provided insights into the genomes of recent cholera isolates and identified several acquired traits including plasmids, transposons, integrative conjugative elements (ICEs), pathogenicity islands (PIs), prophages, and gene cassettes that confer fitness to the pathogen. The knowledge generated from this study would help in better understanding of V. cholerae evolution and management of cholera disease by providing clinical guidance on preferred treatment regimens.

Entities:  

Keywords:  antimicrobial resistance; cholera; genome; mobile genetic elements; proteome

Mesh:

Substances:

Year:  2019        PMID: 30867296      PMCID: PMC6442563          DOI: 10.1073/pnas.1900141116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Atypical integrative element with strand-biased circularization activity assists interspecies antimicrobial resistance gene transfer from Vibrio alfacsensis.

Authors:  Lisa Nonaka; Michiaki Masuda; Hirokazu Yano
Journal:  PLoS One       Date:  2022-08-02       Impact factor: 3.752

2.  Vibrio cholerae O139 genomes provide a clue to why it may have failed to usher in the eighth cholera pandemic.

Authors:  Thandavarayan Ramamurthy; Agila Kumari Pragasam; Alyce Taylor-Brown; Robert C Will; Karthick Vasudevan; Bhabatosh Das; Sunil Kumar Srivastava; Goutam Chowdhury; Asish K Mukhopadhyay; Shanta Dutta; Balaji Veeraraghavan; Nicholas R Thomson; Naresh C Sharma; Gopinath Balakrish Nair; Yoshifumi Takeda; Amit Ghosh; Gordon Dougan; Ankur Mutreja
Journal:  Nat Commun       Date:  2022-07-05       Impact factor: 17.694

3.  Prediction of Antibiotic Susceptibility Profiles of Vibrio cholerae Isolates From Whole Genome Illumina and Nanopore Sequencing Data: CholerAegon.

Authors:  Valeria Fuesslin; Sebastian Krautwurst; Akash Srivastava; Doris Winter; Britta Liedigk; Thorsten Thye; Silvia Herrera-León; Shirlee Wohl; Jürgen May; Julius N Fobil; Daniel Eibach; Manja Marz; Kathrin Schuldt
Journal:  Front Microbiol       Date:  2022-06-22       Impact factor: 6.064

4.  Diverse Aquatic Animal Matrices Play a Key Role in Survival and Potential Virulence of Non-O1/O139 Vibrio cholerae Isolates.

Authors:  Lili Yan; Yinzhe Jin; Beiyu Zhang; Yingwei Xu; Xu Peng; Si Qin; Lanming Chen
Journal:  Front Microbiol       Date:  2022-06-21       Impact factor: 6.064

5.  Molecular insights into the genome dynamics and interactions between core and acquired genomes of Vibrio cholerae.

Authors:  Archana Pant; Satyabrata Bag; Bipasa Saha; Jyoti Verma; Pawan Kumar; Sayantan Banerjee; Bhoj Kumar; Yashwant Kumar; Anbumani Desigamani; Suhrid Maiti; Tushar K Maiti; Sanjay K Banerjee; Rupak K Bhadra; Hemanta Koley; Shanta Dutta; G Balakrish Nair; Thandavarayan Ramamurthy; Bhabatosh Das
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-01       Impact factor: 11.205

6.  Antimicrobial Activity of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) against Clinical Isolates of Multidrug-Resistant Vibrio cholerae.

Authors:  Achiraya Siriphap; Anong Kiddee; Acharaporn Duangjai; Atchariya Yosboonruang; Grissana Pook-In; Surasak Saokaew; Orasa Sutheinkul; Anchalee Rawangkan
Journal:  Antibiotics (Basel)       Date:  2022-04-13

Review 7.  Foodborne Pathogenic Vibrios: Antimicrobial Resistance.

Authors:  Dipanjan Dutta; Anupam Kaushik; Dhirendra Kumar; Satyabrata Bag
Journal:  Front Microbiol       Date:  2021-06-30       Impact factor: 5.640

8.  Antibiotic Resistance in Vibrio cholerae: Mechanistic Insights from IncC Plasmid-Mediated Dissemination of a Novel Family of Genomic Islands Inserted at trmE.

Authors:  Nicolas Rivard; Rita R Colwell; Vincent Burrus
Journal:  mSphere       Date:  2020-08-26       Impact factor: 4.389

9.  Phenotypic and Genotypic Antimicrobial Resistance Traits of Vibrio cholerae Non-O1/Non-O139 Isolated From a Large Austrian Lake Frequently Associated With Cases of Human Infection.

Authors:  Sarah Lepuschitz; Sandrine Baron; Emeline Larvor; Sophie A Granier; Carina Pretzer; Robert L Mach; Andreas H Farnleitner; Werner Ruppitsch; Sonja Pleininger; Alexander Indra; Alexander K T Kirschner
Journal:  Front Microbiol       Date:  2019-11-08       Impact factor: 5.640

10.  Pathogenicity and virulence regulation of Vibrio cholerae at the interface of host-gut microbiome interactions.

Authors:  Ansel Hsiao; Jun Zhu
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.